| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $298.5M | +11.8% |
| R&D Expense | $54.4M | +42.9% |
| SG&A Expense | $81.4M | +23.0% |
| Operating Income | -$457.8M | -273.4% |
| Interest Expense | $3.8M | -70.4% |
| Pre-tax Income | -$466.7M | -242.1% |
| Income Tax | -$1.4M | -118.4% |
| Net Income | -$465.3M | -261.9% |
| EPS (Basic) | -$13.92 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $121.9M | -47.8% |
| Accounts Receivable | $115.6M | +4.1% |
| Current Assets | $250.0M | -30.3% |
| Total Assets | $691.2M | -45.3% |
| Current Liabilities | $248.9M | -24.0% |
| Long-term Debt | $226.0M | +22.6% |
| Total Liabilities | $479.6M | -16.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$53.9M | -39.9% |
| Capital Expenditures | $1.2M | -62.3% |
| Investing Cash Flow | -$15.8M | +96.9% |
| Financing Cash Flow | -$40.0M | -108.2% |
| Free Cash Flow | -$55.1M | -32.3% |
| -248.9% |
| Stockholders' Equity |
| $211.6M |
| -69.4% |